CDH1 and neoplasm: In the tumor, we observe a loss of the E-cadherin protein due to the inactivation of CDH1 gene by combining a first hit, mainly a truncating variant to a second hit causing the methylation of CDH1 promotor (50%) or a loss of heterozygosity in favor of the pathogenic first hit (50%) [12,13,14].